Cargando…

Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma

Background: 5-Hydroxymethylcytosine (5hmC) with dynamic existence possesses multiple regulatory functions. Whereas, 5hmC’s impact on small hepatocellular carcinoma (SHCC) remains unclear. The present work focused on characterizing 5hmC content within SHCC and assessing the possibility of using globa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jinhua, Yan, Tinghua, Guo, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534723/ https://www.ncbi.nlm.nih.gov/pubmed/34677239 http://dx.doi.org/10.3390/curroncol28050321

Ejemplares similares

Exploring role of 5hmC as potential marker of chemoresistance
por: Kharat, Suhas S., et al.
Publicado: (2020)

TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
por: Lio, Chan-Wang J., et al.
Publicado: (2019)

Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
por: Stöger, Reinhard, et al.
Publicado: (2017)

New Insights into 5hmC DNA Modification: Generation, Distribution and Function
por: Shi, Dong-Qiao, et al.
Publicado: (2017)

5hmC modification regulates R-loop accumulation in response to stress
por: Xu, Xingyun, et al.
Publicado: (2023)

Crystal structure of the 5hmC specific endonuclease PvuRts1I
por: Kazrani, Asgar Abbas, et al.
Publicado: (2014)

De novo DNA methylation drives 5hmC accumulation in mouse zygotes
por: Amouroux, Rachel, et al.
Publicado: (2016)

Alterations in the Genomic Distribution of 5hmC in In Vivo Aged Human Skin Fibroblasts
por: Kołodziej-Wojnar, Paulina, et al.
Publicado: (2020)

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms
por: Seethy, Ashikh A., et al.
Publicado: (2023)

5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary
por: Khare, Tarang, et al.
Publicado: (2012)

Combined methylation mapping of 5mC and 5hmC during early embryonic stages in bovine
por: de Montera, Béatrice, et al.
Publicado: (2013)

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis
por: Guo, Xiao-Jun, et al.
Publicado: (2023)

Analysis of archaic human haplotypes suggests that 5hmC acts as an epigenetic guide for NCO recombination
por: Lee, Bernett, et al.
Publicado: (2022)

Standardized Computer-Assisted Analysis of 5-hmC Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
por: Koch, Elias A. T., et al.
Publicado: (2023)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers
por: Wang, Zhihui, et al.
Publicado: (2020)

5mC and 5hmC dynamics during PGC reprogramming and role of Tet1 in female meiosis
por: Yamaguchi, Shinpei, et al.
Publicado: (2013)

IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC
por: Xu, Qiang, et al.
Publicado: (2016)

Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion
por: Zhang, Zijing, et al.
Publicado: (2019)

Social defeat stress induces genome-wide 5mC and 5hmC alterations in the mouse brain
por: Kuehner, Janise N, et al.
Publicado: (2023)

Species-Specific 5 mC and 5 hmC Genomic Landscapes Indicate Epigenetic Contribution to Human Brain Evolution
por: Madrid, Andy, et al.
Publicado: (2018)

Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC)
por: Chu, Yajing, et al.
Publicado: (2018)

iRNA5hmC: The First Predictor to Identify RNA 5-Hydroxymethylcytosine Modifications Using Machine Learning
por: Liu, Yuan, et al.
Publicado: (2020)

5-Hydroxymethylcytosine (5hmC) at or near cancer mutation hot spots as potential targets for early cancer detection
por: Lu, Michael J., et al.
Publicado: (2022)

Genome-wide 5-hydroxymethylcytosine (5hmC) reassigned in Pten-depleted mESCs along neural differentiation
por: Wang, Zhangting, et al.
Publicado: (2022)

A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds
por: Cao, Dongyi, et al.
Publicado: (2020)

Supplemental Herbal Choline Increases 5-hmC DNA on Whole Blood from Pregnant Ewes and Offspring
por: Roque-Jiménez, José Alejandro, et al.
Publicado: (2020)

TET2 Promotes Keloid Hyperplasia by Regulating 5hmC Modification in the TGFβ Promoter Region
por: Niu, Changying, et al.
Publicado: (2023)

Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy
por: Liang, Guanghao, et al.
Publicado: (2023)

Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males
por: Olszewska, Marta, et al.
Publicado: (2022)

HPV infection and 5mC/5hmC epigenetic markers in penile squamous cell carcinoma: new insights into prognostics
por: Santos, Renan da Silva, et al.
Publicado: (2022)

Genome-wide 5-hydroxymethylcytosine (5hmC) emerges at early stage of in vitro differentiation of a putative hepatocyte progenitor
por: Rodríguez-Aguilera, Jesús Rafael, et al.
Publicado: (2020)

β2SP/TET2 complex regulates gene 5hmC modification after cerebral ischemia
por: Ma, Xiaohua, et al.
Publicado: (2021)

TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer
por: Chi, Jiadong, et al.
Publicado: (2022)

Array-based assay detects genome-wide 5-mC and 5-hmC in the brains of humans, non-human primates, and mice
por: Chopra, Pankaj, et al.
Publicado: (2014)

Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
por: Sajadian, Sahar Olsadat, et al.
Publicado: (2015)

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Li, Shuangquan, et al.
Publicado: (2022)

Analysis of the machinery and intermediates of the 5hmC-mediated DNA demethylation pathway in aging on samples from the MARK-AGE Study
por: Valentini, Elisabetta, et al.
Publicado: (2016)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ms8nl8g52454e6hpdr688ohvdr